Interferon beta-1b
Generic name: Interferon Beta-1b
Dosage form: subcutaneous powder for injection (0.3 mg)
Drug class:
Interferons
Usage of Interferon beta-1b
Interferon beta-1b is used to treat is used to treat relapsing forms of multiple sclerosis (MS). interferon beta-1b will not cure MS, but it may decrease flare-ups.
Interferon beta-1b may also be used for purposes not listed in this medication guide.
Interferon beta-1b side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some patients using interferon medicines have become very depressed or had thoughts of suicide. Report any new or worsening symptoms of depression to your doctor, such as: mood or behavior changes, anxiety, trouble sleeping, hallucinations, or if you feel impulsive, hostile, aggressive, depressed, or have thoughts about suicide or hurting yourself.
Interferon beta-1b may cause serious side effects. Stop using interferon beta-1b and call your doctor at once if you have:
Common side effects of interferon beta-1b may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Interferon beta-1b
You should not use interferon beta-1b if you are allergic to interferon beta, albumin, or mannitol.
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant or breastfeeding.
Relate drugs
- Actimmune
- Alferon N
- Avonex
- Avonex Pen
- Avonex Prefilled Syringe
- Betaseron
- Extavia
- Interferon alfa-n3
- Interferon beta-1a
- Interferon beta-1b
- Interferon gamma-1b
- Peginterferon beta-1a
- Plegridy
- Plegridy Pen
- Plegridy Pen Starter Pack
- Rebif
- Rebif Rebidose
- Rebif Rebidose Titration Pack
How to use Interferon beta-1b
Usual Adult Dose for Multiple Sclerosis:
Initial dose: 0.0625 mg subcutaneously every other day, and increased (in 25% increments) every 2 weeks, over a 6 week period, to maintenance doseMaintenance dose: 0.25 mg subcutaneously every other daySchedule for dose titration:Weeks 1 and 2: 0.0625 mg subcutaneously every other day (25% of recommended dose)Weeks 3 and 4: 0.125 mg subcutaneously every other day (50% of recommended dose)Weeks 5 and 6: 0.1875 mg subcutaneously every other day (75% of recommended dose)Week 7 and beyond: 0.25 mg subcutaneously every other day (100% of recommended dose)Use: For the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Warnings
Get emergency medical help if you have signs of a serious allergic reaction, such as a rash, itching, or swelling in your mouth or tongue.
Some people have thoughts about suicide while taking interferon beta-1b. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.
Interferon beta-1b can harm your liver. Call your doctor at once if you have nausea, vomiting, itching, bruising or bleeding, or yellowing of your skin or eyes.
What other drugs will affect Interferon beta-1b
Other drugs may affect interferon beta-1b, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions